Appointment booking for Dr. Harsh Golwala, MD is currently not available.Dr. Harsh Golwala, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Harsh Golwala, MD (he/him) is a Cardiologist, Interventional Cardiologist, Internist in Portland, OR with over 14 years of experience. What is your opinion of Dr. Harsh Golwala, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 14 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Harsh Golwala, MD has received over $15,997 which includes payments from the following companies:
$5,734.19 from Medtronic Vascular, Inc.
$3,788.16 from Abbott Laboratories
$2,641.72 from Edwards Lifesciences Corporation
$1,192.73 from Boston Scientific Corporation
$1,049.32 from Janssen Pharmaceuticals, Inc
$416.95 from AstraZeneca Pharmaceuticals LP
$262.97 from St. Jude Medical, Inc.
$167.12 from Novartis Pharmaceuticals Corporation
$131.48 from Cardiovascular Systems Inc.
$120.66 from Boehringer Ingelheim Pharmaceuticals, Inc.
$115.39 from Pfizer Inc.
$110.07 from Cook Incorporated
$103.72 from The Medicines Company
$99.99 from Gilead Sciences Inc
$48.14 from E.R. Squibb & Sons, L.L.C.
$15.06 from Astellas Pharma US Inc
Payments received by Dr. Harsh Golwala, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!